JPRN-jRCT1080220031未知4 期
Intrathecal Baclofen therapy with the implanted pump system for Spastic Palsy (Post-marketing clinical trial extended phase 3 after NDA approval)
适应症
试验速览
- 阶段
- 4 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patient meeting the criteria for inclusion, who intend to continue the treatment with intrathecal baclofen using the implanted pump system after approval of NDA. The written informed consent by the patients or the legal representative is a must.
- •[Criteria for inclusion]
- •1) Patient effective to the intrathecal baclofen therapy at the long term safety clinical trial(phase 3), and is judged as no safety issue by the doctor.
- •2) Patient who can be regularly followed during clinical trial.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Intrathecal baclofen therapy for management of spasticity: An Australian paediatric multicentre prospective audit.Spinal Cord InjuryNeurological - Other neurological disordersCerebral PalsyACTRN12610000323022Princess Margaret Hospital for Children100
已完成
不适用
Intrathecal Baclofen Infusion for Reflex sympathetic Dystrophy related dystoniaReflex sympathetic dystrophy (RSD)Signs and SymptomsPainISRCTN43633981eiden University Medical Centre (LUMC) (The Netherlands)45
已完成
不适用
The BIRD study. Intrathecal Baclofen Infusion for Reflex Sympathetic Dystrophy related dystonia.Reflex sympathetic dystrophy (RSD) related dystonia.NL-OMON27484eiden University Medical Centre, Dept. of Neurology45
招募中
不适用
Effect of intrathecal baclofen (ITB) therapy in ambulatory patients with generalized spasticityPatients with central neurological suffering and generalized spasticity during walking.NL-OMON27247Sint Maartenskliniek15
进行中（未招募）
不适用
Intrathecal bupivacaine and clonidine for ambulatory knee arthroscopy - Intrathecal bupivacaine and clonidine for ambulatory knee arthroscopyPatients are submitted for ambulatory knee arthroscopyMedDRA version: 8.1Level: LLTClassification code 10023477Term: Knee painEUCTR2006-003513-40-FIKalevi Pihlajamäki60